Author

Adian Valdez

University of Washington

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Neil P. KingiD· 3 shared Rashmi RavichandraniD· 3 shared Alexandra C. WallsiD· 2 shared Alexandra SchäferiD· 2 shared Amin AddetiaiD· 2 shared Cameron StewartiD· 2 shared Catherine TreicheliD· 2 shared David VeesleriD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Neil P. KingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge

Courtney E McDougal, Mark D. Langowski, Daria Nikolaeva, Chengbo Chen, Derek J. Bangs, Adian Valdez, Rashmi Ravichandran, Suna Cheng, Mariah Lofgren, Marlon Dillon, Delante Sanders, Alvaro Molina-Cruz, Azza H. Idris, Kazutoyo Miura, Kelly Lee, , Neil P. King

This study shows that nanoparticle vaccines with oligomannose glycans boost B cell responses and protection against malaria sporozoites compared to other glycan types.

bioRxiv · May 7, 2026 · PreprintImmunology

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccines

Amin Addetia, Alexandra Schäfer, Kaitlin R. Sprouse, Adian Valdez, Ashley Taylor, Mary-Jane Navarro, Jack T Brown, Elizabeth M. Leaf, Marcos C. Miranda, Alexandra C. Walls, Jimin Lee, Nicholas Catanzaro, Catherine Treichel, Isabelle Willoughby, John Powers, , David Veesler

This paper designs multivalent RBD nanoparticle vaccines that overcome immune imprinting and provide broad protection against SARS-CoV-2 variants and sarbecoviruses.

bioRxiv · May 11, 2025 · PreprintImmunology

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV

Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, Nicholas J. Catanzaro, Miranda L. Hubbard, Amin Addetia, Cameron Stewart, Jack T. Brown, Annie Dosey, Adian Valdez, Rashmi Ravichandran, Grace G. Hendricks, Maggie Ahlrichs, Craig Dobbins, Alexis Hand, , Neil P. King

This study develops MERS-CoV vaccines using a protein nanoparticle platform, showing they induce strong neutralizing antibodies and protect mice against MERS-CoV challenge.

bioRxiv · Mar 13, 2024Immunology